MD, PhD Eva Maria Zebedin-Brandl

Zebedin E et al., Leukemic challenge unmasks a requirement for PI3K{delta} in NK-cell-mediated tumor surveillance. Blood, Aug 6, 2008 (Epub ahead of print). Zebedin E, Freissmuth M, Sexl V. Signal interception-based therapies--a double-edged sword in Bcr/abl-induced malignancies? Leuk Lymphoma, 49(4):620-4, 2008. Review. Zebedin E., et al., Effects of duramycin on cardiac voltage-gated ion channels. Naunyn Schmiedebergs Arch Pharmacol. Mar;377(1):87-100, 2008. Ott RG et al., JunB is a gatekeeper for B-lymphoid leukemia. Oncogene, 19;26(33):4863-71, 2007. Zebedin et al., C2C12 skeletal muscle cells adopt cardiac-like sodium current properties in a cardiac cell environment. Am J Physiol Heart Circ Physiol., 292(1):H439-50, 2007. Hilber K et al., Selectivity filter residues contribute unequally to pore stabilization in voltage-gated sodium channels. Biochemistry, 25;44(42):13874-82, 2005. Zebedin E., et al., Fiber type conversion alters inactivation of voltage-dependent sodium currents in murine C2C12 skeletal muscle cells. Am J Physiol Cell Physiol., 287(2):C270-80, 2004.